Canada House Wellness Group Signs Agreement with Fuga Group for Medical and Recreational Supplies and Relocates Headquarters to Quebec | 2021-06-07 | Press Releases



/ NOT FOR DISTRIBUTION TO US NEWSWIRE SERVICES OR DISTRIBUTION IN UNITED STATES /

TORONTO and QUEBEC, June 7, 2021 / CNW / – Canada House Wellness Group (CSE: CHV) (” Canada House “or the” Company “), a fully integrated medical cannabis business, and Groupe Fuga Inc. (” Fuga “) are pleased to announce that they have entered into a Product Acquisition Agreement (the” Agreement “). Under the terms of the agreement, Canada House’s wholly owned subsidiary, Abba Medix Corp. (” Abba “), will distribute Fuga’s first product: Tropicanna Cookies – a variety with unique properties designed to the highest industry standards – to its medical patient base and through its existing recreational sales channels.

Fuga is a producer of medical and recreational cannabis located in Stoneham , Quebec who embarked on the artisanal manufacture of superior quality cannabis and succeeded by adhering to the human approach that defines the company: small batch cultivation in living soil by a dedicated team. Abba specializes in providing high quality medical grade cannabis to patients seeking cannabinoid therapy solutions and currently offers strains developed specifically for military veterans with PTSD exclusively to its patient base. Abba is pleased to add Tropicanna Cookies to its product offering for immediate availability for medical patients Canada -wide and will soon make this product available to recreational users as well.

Canada House also announces that its head office has changed to 551, rue Saint-Marc, Louiseville , Quebec, J5V 2L4, Canada .

“We were driven by a very clear vision from the start of this adventure: that of cultivating cannabis carefully, in small quantities, in order to satisfy the most demanding consumers, and in the process, also to introduce a more human approach. within the industry and a sense of community, ”explains Philippe Laperrière, CEO and founder of Fuga.

“Cannabis Fuga was born from the work of entrepreneurs determined to provide Canadians with a product of truly superior quality, cultivated in a methodical, judicious, inventive manner and capable of competing even with the biggest brands. Today, Fuga and Abba Medix are joining forces to make this exceptional product accessible to people with health problems unable to find better relief in prescription drugs ”, adds Chris Churchill Smith , CEO of Canada House.

Premium quality cannabis

What sets Tropicanna Cookies apart is its high concentration of terpenes, the main focus of Fuga. Developed by legendary cannabis breeder Oni Seeds from the parentage of Tangie and Girl Scout Cookies, this strain won the IC420 Growers Cup in 2019. With its bright purple buds and pungent aroma, Tropicanna Cookies will wow even the most sophisticated connoisseur. and novice users. . Energizing and stimulating, it delivers a pure tonic invigorating effect.

From the start, Fuga vowed to grow cannabis like no other, and to do so in a sustainable way, tapping into the passion of the team and driving customer satisfaction. That’s why Fuga chooses to harvest their plants in small batches, sort and cut them by hand, and mature them over several weeks to get the best product.

Fuga is committed to doing good

The story that sparked the advent of Fuga is at the heart of the values ​​that drive the company.

Philippe Laperrière suffered a serious head injury following a serious mountain biking accident. Unable to work due to the effects of the injury, he discovered that hockey players and other athletic athletes used cannabis products to treat the most persistent concussion symptoms. “I have never been a user, so the idea has never crossed my mind before. The sale of cannabis had just been legalized, so I gave it a try. My symptoms were totally gone.”

It was then that the idea of ​​starting a business in this industry that would benefit both users and workers began to emerge.

Fuga (which means “flight” in Latin) took off shortly after. “But it was imperative that the values ​​projected by Fuga were not empty slogans,” continues the founder and CEO of the company. Which is why he opted for small-scale cultivation of quality produce and adopted organic cultivation. “It’s not the most profitable way to make a quick buck, but I want our company to embody the values ​​it stands for. For users and for our employees, so that everyone can benefit from the best practices. ”

About Canada House Wellness Group

Canada House Wellness Group is the parent company of Abba Medix Corp., a licensed producer in Pickering, Ontario that produces high quality medical grade cannabis; IsoCanMed Inc., a licensed producer in Louiseville , Quebec grows the best indoor cannabis in its class, in its 64,000 square foot production facility using cutting edge vertical aeroponic production methodologies; Canada House Clinics Inc., with clinics across the country working directly with primary care teams to provide specialized cannabinoid therapy services to patients with simple and complex medical conditions; and Knalysis Technologies, a provider of fully customizable, cloud-based software that connects physician, provider, and patient with data that supports medical cannabis treatment.

The goal of Canada House Wellness Group is to become the leading premium artisanal cannabis grower and provider of cannabinoid therapy, targeting medical cannabis markets globally. Please visit www.canadahouse.ca or the Company’s public documents at www.sedar.com.

About Fuga:

Groupe Fuga Inc. is a private company based in Stoneham , Quebec. Approved by Health Canada since October 2020 , it produces cannabis for medical and recreational purposes. Fuga operates a $ 4 million , an 800 m² microculture facility 30 minutes north of Quebec City, where she uses the organic living soil method to produce her unique brand of cannabis. The company plans to generate 10 full-time jobs. To learn more about Fuga’s origin story, visit www.fuga.ca.

Caution regarding forward-looking information. This press release contains forward-looking statements, including statements relating to, among other things, the Company’s clinical, production and technology activities, future plans, markets, objectives, goals, strategies, intentions, beliefs, expectations and Company estimates, and can generally be identified by the use of words such as “may”, “will”, “could”, “should”, “would”, “likely”, “possible”, “expect” to “,” intend “,” estimate “,” anticipate “,” believe “,” plan “,” objective “and” continue “(or the negative thereof) and words and expressions of similar significance . Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, such statements involve risks and uncertainties, and such statements should not be relied upon. Certain important factors or assumptions are applied in forward-looking statements, and the actual results can be t differ materially from those expressed or implied in these statements. The important assumptions used to develop forward-looking information in this press release include, among others, the regulations relating to the consumption of cannabis under the Regulation respecting access to cannabis for medical purposes and the Act respecting cannabis and amending the Controlled Drugs and Substances Act, the Criminal Code and other laws, passed by the Canadian federal government, legalizing cannabis and edible cannabis products, vapes and oils for recreational use on Oct. 17, 2018 and October 17, 2019 ; The company’s liquidity and capital resources, including the availability of additional capital resources to finance its activities; level of competition; the ability to adapt products and services to changing market conditions; the ability to attract and retain key executives; and the ability to execute strategic plans. Additional information on material factors that could cause actual results to differ materially from expectations and on material factors or assumptions applied in making forward-looking statements can be found in the most recent annual and interim MD&A of the Company. Company under “Risks and Uncertainties” as well as in other public information documents filed with Canadian securities regulators. The Company assumes no obligation to publicly update or revise any forward-looking statements contained herein, whether as a result of new information, future events or otherwise, except as required by law.

Neither CSE nor its regulatory services provider (as that term is defined in CSE policies) accepts responsibility for the adequacy or accuracy of this release.

SOURCE Canada House Wellness Group Inc.

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2021/07/c0871.html



Source link

Previous The story of Out-of-Knotting - SUNSTAR
Next What it was like to attend the clubhouse's very first wedding